Hi, what are you looking for?

Diaphragm valves use a flexible diaphragm to block, control, or divert fluid flow. The diaphragm acts as a flexible flow control element to increase or decrease the flow of fluid. The valve closure action is performed as the diaphragm is pressed into a solid dam inside the valve body. Diaphragm valves are classified as moving line valves, requiring direct movement of the flow control element. The valve can be operated manually or pneumatically and controlled by control peaks and solenoid valves.

According to the latest report published by Transparency Market Research, the global hygienic diaphragm valves in biopharma market is expected to grow, owing to its favorable properties, specifically for applications in water for injection (WFI), biopharma microbiology, and bio production.

The global hygienic diaphragm valves in biopharma market was valued at US$ 267.1 Mn in 2021. It is estimated to grow at a CAGR of 4.7% from 2022 to 2031. The global hygienic diaphragm valves in biopharma market is expected to reach value of US$ 408.8 Mn by the end of 2031.

In terms of type, the inline processing valve segment reached US$ 200.8 Mn in 2021, and is expected to dominate the market during the forecast period. Hygienic diaphragm valves in the biopharma market are classified into inline processing valves and tank valves. Inline processing valves essentially have the same design as other valves except that their inlet and outlet is located on the axis. The flow resistance of inline processing valves is generally higher than that of comparable angle valves due to their design. Valves with small diaphragms are available as diaphragm valves. Line radial diaphragm valves provide a clean and inexpensive solution for the transfer of sterile fluid to medical procedures that makes it more appropriate for consumers.

In 2021, North America had maximum share in the global hygienic diaphragm valves in biopharma market at 30.4%, followed by Europe with 28.7% share. The hygienic diaphragm valves in biopharma market in Asia Pacific has been growing significantly and is expected to grow at almost 5% rate during the forecast period, owing to the advancement of pharmaceuticals, biotechnological, and bioprocessing sectors in India and China. The growth can be attributed to economic developments in China and India, which has propelled investments in the biopharma sector and is likely to lead to the demand for diaphragm valves.

Additionally, increasing research & development, along with production across the globe has also contributed to the growing demand for hygienic diaphragm valves in biopharma market.

The hygienic diaphragm valves in biopharma market is consolidated with a limited number of large-scale vendors controlling majority of the market share. Several firms are spending significantly on a comprehensive research and development, primarily to develop environment-friendly products. Diversification of product portfolios and mergers & acquisitions are the key strategies adopted by key market vendors in diaphragm valves that include Alfa Laval Corporate AB, Aquasyn LLC, Christian Bürkert GmbH & Co. KG, Emerson Electric Co, Entegris, Inc., GEA Group AG, Georg Fischer Ltd., PBM, Inc., RATTIINOX SRL, GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG, Crane Co., ITT Engineered Valves, LLC, Fujikin Inc., Sed Flow Control GmbH, and Inoxpa Sau.

Each of these players has been profiled in the hygienic diaphragm valves in biopharma market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

More Trending Reports by Transparency Market Research –

Got a problem? Yes, you do. Fix it. Try “Life, Liberty, and the Pursuit of Happiness.” You could do worse.

The 54-year-old designer told AFP the diplomatic gesture was a "special, magical moment" for him after years spent working on the bike.

To stay ahead of cybercriminals, companies must address vulnerability exposure risks before hackers attack them.

The Ukrainian govt. issues a daily catalogue of Russia's losses in the four-month long war, while remaining cagey about its own casualties.

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.